| Sr No. |
|
Additional disclosure of related
party transactions - applicable only in case the related party transaction relates to loans,
inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary.
These details need to be disclosed only once, during the reporting period when such transaction was
undertaken. |
| Details of the party (listed entity/subsidiary) entering into the transaction |
Details of the counterparty |
Type of related party transaction |
Details of other related party transaction |
Value of the related party transaction as approved by the audit committee |
Remarks on approval by audit committee |
Value of the related party transaction ratified by the audit committee |
Date of Audit Committee Meeting where the ratification was approved |
Value of transaction during the reporting period |
In case monies are due to either party as a result of the transaction |
In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments |
Details of the loans, inter-corporate deposits, advances or investments |
Notes |
| Name |
PAN |
Name |
PAN |
Relationship of the counterparty with the listed entity or its subsidiary |
Opening balance |
Closing balance |
Nature of indebtedness (loan/ issuance of debt/ any other etc.) |
Details of other indebtedness |
Cost |
Tenure |
Nature (loan/ advance/ intercorporate deposit/ investment ) |
Interest Rate (%) |
Tenure |
Secured/ unsecured |
Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage) |
| 1 |
Emcure Pharmaceuticals Limited |
|
Zuventus Healthcare Limited |
|
Subsidiaries |
Purchase of goods or services |
|
3,000.00 |
Approved |
|
|
252.90 |
(37.50) |
(38.60) |
|
|
|
|
|
|
|
|
|
|
| 2 |
Emcure Pharmaceuticals Limited |
|
Gennova Biopharmaceuticals Limited |
|
Subsidiaries |
Purchase of goods or services |
|
20,000.00 |
Approved |
|
|
5,185.30 |
(951.10) |
(611.80) |
|
|
|
|
|
|
|
|
|
|
| 3 |
Emcure Pharmaceuticals Limited |
|
Uth Beverages Factory Pvt. Ltd. |
|
Enterprise over which Key Management Personnel have control |
Purchase of goods or services |
|
1,000.00 |
Approved |
|
|
43.90 |
10.80 |
(1.90) |
|
|
|
|
|
|
|
|
|
|
| 4 |
Emcure Pharmaceuticals Limited |
|
Gennova Biopharmaceuticals Limited |
|
Subsidiaries |
Sale of fixed assets |
|
1,000.00 |
Approved |
|
|
2.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 5 |
Emcure Pharmaceuticals Limited |
|
Zuventus Healthcare Limited |
|
Subsidiaries |
Sale of goods or services |
|
6,000.00 |
Approved |
|
|
1,402.10 |
0.00 |
537.60 |
|
|
|
|
|
|
|
|
|
|
| 6 |
Emcure Pharmaceuticals Limited |
|
Gennova Biopharmaceuticals Limited |
|
Subsidiaries |
Sale of goods or services |
|
10,000.00 |
Approved |
|
|
4,197.30 |
1,688.80 |
3,230.90 |
|
|
|
|
|
|
|
|
|
|
| 7 |
Emcure Pharmaceuticals Limited |
|
Emcure Lifesciences Private Limited |
|
Subsidiaries |
Sale of goods or services |
|
13,200.00 |
Approved |
|
|
1,526.80 |
0.00 |
1,435.80 |
|
|
|
|
|
|
|
|
|
|
| 8 |
Emcure Pharmaceuticals Limited |
|
Tillomed Laboratories Limited |
|
Holding-Subsidiary |
Sale of goods or services |
|
71,500.00 |
Approved |
|
|
17,580.40 |
(9,722.10) |
1,201.70 |
|
|
|
|
|
|
|
|
|
|
| 9 |
Emcure Pharmaceuticals Limited |
|
Tillomed Malta Limited |
|
Subsidiaries |
Sale of goods or services |
|
50,000.00 |
Approved |
|
|
15,821.70 |
16,951.80 |
24,295.40 |
|
|
|
|
|
|
|
|
|
|
| 10 |
Emcure Pharmaceuticals Limited |
|
Tillomed Italia S.R.L, Italy |
|
Subsidiaries |
Sale of goods or services |
|
20,000.00 |
Approved |
|
|
11,088.00 |
15,177.60 |
14,861.80 |
|
|
|
|
|
|
|
|
|
|
| 11 |
Emcure Pharmaceuticals Limited |
|
Marcan Pharmaceuticals Inc. |
|
Subsidiaries |
Sale of goods or services |
|
51,500.00 |
Approved |
|
|
15,953.10 |
(588.20) |
1,304.70 |
|
|
|
|
|
|
|
|
|
|
| 12 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharmaceuticals South Africa (Pty) Ltd |
|
Subsidiaries |
Sale of goods or services |
|
60,000.00 |
Approved |
|
|
17,604.40 |
15,107.50 |
8,087.90 |
|
|
|
|
|
|
|
|
|
|
| 13 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharmaceuticals Mena FZ-LLC. |
|
Subsidiaries |
Sale of goods or services |
|
20,000.00 |
Approved |
|
|
1,054.30 |
1,991.10 |
536.70 |
|
|
|
|
|
|
|
|
|
|
| 14 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharma Peru S.A.C. |
|
Subsidiaries |
Sale of goods or services |
|
5,400.00 |
Approved |
|
|
931.40 |
5,487.80 |
5,615.50 |
|
|
|
|
|
|
|
|
|
|
| 15 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharma Chile SpA |
|
Subsidiaries |
Sale of goods or services |
|
7,500.00 |
Approved |
|
|
1,499.80 |
5,765.00 |
4,638.00 |
|
|
|
|
|
|
|
|
|
|
| 16 |
Emcure Pharmaceuticals Limited |
|
Lazor Pharmaceuticals Limited |
|
Subsidiaries |
Sale of goods or services |
|
5,000.00 |
Approved |
|
|
658.70 |
973.70 |
1,223.60 |
|
|
|
|
|
|
|
|
|
|
| 17 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharma Philippines Inc |
|
Subsidiaries |
Sale of goods or services |
|
2,000.00 |
Approved |
|
|
225.60 |
386.30 |
581.80 |
|
|
|
|
|
|
|
|
|
|
| 18 |
Emcure Pharmaceuticals Limited |
|
Avet Lifesciences Private Limited |
|
Enterprise over which Key Management Personnel have control |
Sale of goods or services |
|
50,000.00 |
Approved |
|
|
13,117.00 |
16,674.60 |
24,083.90 |
|
|
|
|
|
|
|
|
|
|
| 19 |
Emcure Pharmaceuticals Limited |
|
Heritage Pharma Labs Inc. |
|
Enterprise over which Key Management Personnel have control |
Sale of goods or services |
|
8,500.00 |
Approved |
|
|
813.80 |
480.50 |
753.60 |
|
|
|
|
|
|
|
|
|
|
| 20 |
Emcure Pharmaceuticals Limited |
|
Heritage Pharmaceuticals Inc. |
|
Enterprise over which Key Management Personnel have control |
Sale of goods or services |
|
8,500.00 |
Approved |
|
|
2,557.70 |
1,954.70 |
2,382.80 |
|
|
|
|
|
|
|
|
|
|
| 21 |
Emcure Pharmaceuticals Limited |
|
H.M. Sales Corporation |
|
Enterprise over which Key Management Personnel have control |
Sale of goods or services |
|
2,500.00 |
Approved |
|
|
185.80 |
70.60 |
168.90 |
|
|
|
|
|
|
|
|
|
|
| 22 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharma Mexico S.A. DE C.V. |
|
Subsidiaries |
Sale of goods or services |
|
1,800.00 |
Approved |
|
|
119.00 |
49.60 |
174.40 |
|
|
|
|
|
|
|
|
|
|
| 23 |
Emcure Pharmaceuticals Limited |
|
Gennova Biopharmaceuticals Limited |
|
Subsidiaries |
Investment |
|
0.00 |
Not applicable |
|
|
32.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 24 |
Emcure Pharmaceuticals Limited |
|
Zuventus Healthcare Limited |
|
Subsidiaries |
Investment |
|
0.00 |
Not applicable |
|
|
36.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 25 |
Emcure Pharmaceuticals Limited |
|
Emcutix Biopharmaceuticals Limited |
|
Subsidiaries |
Investment |
|
0.00 |
Not applicable |
|
|
3.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 26 |
Emcure Pharmaceuticals Limited |
|
Marcan Pharmaceuticals Inc. |
|
Subsidiaries |
Investment |
|
0.00 |
Not applicable |
|
|
0.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 27 |
Emcure Pharmaceuticals Limited |
|
Tillomed Laboratories Limited |
|
Holding-Subsidiary |
Investment |
|
0.00 |
Not applicable |
|
|
25.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 28 |
Emcure Pharmaceuticals Limited |
|
Gennova Biopharmaceuticals Limited |
|
Subsidiaries |
Inter-corporate deposit |
|
40,000.00 |
Approved |
|
|
12,498.00 |
35,564.00 |
28,662.00 |
|
|
|
|
Inter-corporate deposit |
7.500 |
36 |
Unsecured |
General Purpose |
|
| 29 |
Emcure Pharmaceuticals Limited |
|
Emcutix Biopharmaceuticals Limited |
|
Subsidiaries |
Inter-corporate deposit |
|
10,000.00 |
Approved |
|
|
1,105.00 |
2,804.00 |
3,269.00 |
|
|
|
|
Inter-corporate deposit |
7.500 |
36 |
Unsecured |
General Purpose |
|
| 30 |
Emcure Pharmaceuticals Limited |
|
Emcure Wellness Private Limited |
|
Subsidiaries |
Inter-corporate deposit |
|
10,000.00 |
Approved |
|
|
175.00 |
265.00 |
440.00 |
|
|
|
|
Inter-corporate deposit |
7.500 |
36 |
Unsecured |
General Purpose |
|
| 31 |
Emcure Pharmaceuticals Limited |
|
Emcure Lifesciences Private Limited |
|
Subsidiaries |
Inter-corporate deposit |
|
10,000.00 |
Approved |
|
|
1,115.00 |
500.00 |
0.00 |
|
|
|
|
Inter-corporate deposit |
7.500 |
36 |
Unsecured |
General Purpose |
|
| 32 |
Emcure Pharmaceuticals Limited |
|
Gennova Biopharmaceuticals Limited |
|
Subsidiaries |
Inter-corporate deposit |
|
0.00 |
Not applicable |
|
|
19,400.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 33 |
Emcure Pharmaceuticals Limited |
|
Emcutix Biopharmaceuticals Limited |
|
Subsidiaries |
Inter-corporate deposit |
|
0.00 |
Not applicable |
|
|
640.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 34 |
Emcure Pharmaceuticals Limited |
|
Emcure Lifesciences Private Limited |
|
Subsidiaries |
Inter-corporate deposit |
|
0.00 |
Not applicable |
|
|
1,615.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 35 |
Emcure Pharmaceuticals Limited |
|
Zuventus Healthcare Limited |
|
Subsidiaries |
Inter-corporate deposit |
|
60,000.00 |
Approved |
|
|
27,003.00 |
(55,720.00) |
(65,525.00) |
|
|
|
|
Inter-corporate deposit |
7.500 |
36 |
Unsecured |
General Purpose |
|
| 36 |
Emcure Pharmaceuticals Limited |
|
Zuventus Healthcare Limited |
|
Subsidiaries |
Inter-corporate deposit |
|
0.00 |
Not applicable |
|
|
17,198.00 |
0.00 |
0.00 |
|
|
|
|
Inter-corporate deposit |
7.500 |
36 |
Unsecured |
General Purpose |
|
| 37 |
Emcure Pharmaceuticals Limited |
|
Gennova Biopharmaceuticals Limited |
|
Subsidiaries |
Interest received |
|
3,200.00 |
Approved |
|
|
1,293.80 |
0.00 |
155.60 |
|
|
|
|
|
|
|
|
|
|
| 38 |
Emcure Pharmaceuticals Limited |
|
Emcutix Biopharmaceuticals Limited |
|
Subsidiaries |
Interest received |
|
800.00 |
Approved |
|
|
123.00 |
0.00 |
37.20 |
|
|
|
|
|
|
|
|
|
|
| 39 |
Emcure Pharmaceuticals Limited |
|
Emcure Wellness Private Limited |
|
Subsidiaries |
Interest received |
|
1,000.00 |
Approved |
|
|
15.10 |
0.00 |
5.00 |
|
|
|
|
|
|
|
|
|
|
| 40 |
Emcure Pharmaceuticals Limited |
|
Emcure Lifesciences Private Limited |
|
Subsidiaries |
Interest received |
|
1,000.00 |
Approved |
|
|
20.70 |
0.00 |
6.80 |
|
|
|
|
|
|
|
|
|
|
| 41 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharma Philippines Inc |
|
Subsidiaries |
Interest received |
|
0.00 |
Not applicable |
|
|
20.50 |
108.40 |
130.20 |
|
|
|
|
|
|
|
|
|
|
| 42 |
Emcure Pharmaceuticals Limited |
|
H.M. Sales Corporation |
|
Enterprise over which Key Management Personnel have control |
Interest paid |
|
0.00 |
Not applicable |
|
|
3.80 |
(1.70) |
(1.70) |
|
|
|
|
|
|
|
|
|
|
| 43 |
Emcure Pharmaceuticals Limited |
|
Zuventus Healthcare Limited |
|
Subsidiaries |
Interest paid |
|
5,000.00 |
Approved |
|
|
2,289.50 |
0.00 |
(718.90) |
|
|
|
|
|
|
|
|
|
|
| 44 |
Emcure Pharmaceuticals Limited |
|
Mr. Satish Mehta |
|
Promoters |
Remuneration |
|
6,000.00 |
Approved |
|
|
1,709.70 |
(1,113.80) |
(613.80) |
|
|
|
|
|
|
|
|
|
|
| 45 |
Emcure Pharmaceuticals Limited |
|
Mr. Sunil Mehta |
|
Promoters |
Remuneration |
|
6,000.00 |
Approved |
|
|
274.50 |
(58.30) |
(58.30) |
|
|
|
|
|
|
|
|
|
|
| 46 |
Emcure Pharmaceuticals Limited |
|
Mrs. Namita Thapar |
|
Promoters |
Remuneration |
|
6,000.00 |
Approved |
|
|
274.50 |
(57.80) |
(57.80) |
|
|
|
|
|
|
|
|
|
|
| 47 |
Emcure Pharmaceuticals Limited |
|
Mr. Samit Mehta |
|
Promoters |
Remuneration |
|
6,000.00 |
Approved |
|
|
193.90 |
(38.50) |
(38.50) |
|
|
|
|
|
|
|
|
|
|
| 48 |
Emcure Pharmaceuticals Limited |
|
Mr. Vikas Thapar |
|
Promoters Group |
Remuneration |
|
6,000.00 |
Approved |
|
|
274.50 |
(57.80) |
(57.80) |
|
|
|
|
|
|
|
|
|
|
| 49 |
Emcure Pharmaceuticals Limited |
|
Mr. Sanjay Mehta |
|
Promoter Group |
Remuneration |
|
6,000.00 |
Approved |
|
|
274.50 |
(58.30) |
(58.30) |
|
|
|
|
|
|
|
|
|
|
| 50 |
Emcure Pharmaceuticals Limited |
|
Mr. Rutav Mehta |
|
Promoter Group |
Remuneration |
|
6,000.00 |
Approved |
|
|
32.00 |
(6.00) |
(6.00) |
|
|
|
|
|
|
|
|
|
|
| 51 |
Emcure Pharmaceuticals Limited |
|
Gennova Biopharmaceuticals Limited |
|
Subsidiaries |
Any other transaction |
Laboratory Service Income |
50.00 |
Approved |
|
|
0.30 |
0.30 |
0.20 |
|
|
|
|
|
|
|
|
|
|
| 52 |
Emcure Pharmaceuticals Limited |
|
Zuventus Healthcare Limited |
|
Subsidiaries |
Any other transaction |
Laboratory Service Income |
200.00 |
Approved |
|
|
1.00 |
0.00 |
0.10 |
|
|
|
|
|
|
|
|
|
|
| 53 |
Emcure Pharmaceuticals Limited |
|
Gennova Biopharmaceuticals Limited |
|
Subsidiaries |
Any other transaction |
Trade / Security deposits accepted |
0.00 |
Not applicable |
|
|
9.90 |
(541.10) |
(551.00) |
|
|
|
|
|
|
|
|
|
|
| 54 |
Emcure Pharmaceuticals Limited |
|
H.M. Sales Corporation |
|
Enterprise over which Key Management Personnel have control |
Any other transaction |
Commission expenses |
1,000.00 |
Approved |
|
|
162.20 |
(63.50) |
(77.00) |
|
|
|
|
|
|
|
|
|
|
| 55 |
Emcure Pharmaceuticals Limited |
|
Gennova Biopharmaceuticals Limited |
|
Subsidiaries |
Any other transaction |
Reimbursement of expenses made |
0.00 |
Not applicable |
|
|
29.20 |
(20.20) |
(7.80) |
|
|
|
|
|
|
|
|
|
|
| 56 |
Emcure Pharmaceuticals Limited |
|
Marcan Pharmaceuticals Inc. |
|
Subsidiaries |
Any other transaction |
Reimbursement of expenses made |
0.00 |
Not applicable |
|
|
158.60 |
(186.70) |
(344.50) |
|
|
|
|
|
|
|
|
|
|
| 57 |
Emcure Pharmaceuticals Limited |
|
Mantra Pharma Inc |
|
Holding-Subsidiary |
Any other transaction |
Reimbursement of expenses made |
0.00 |
Not applicable |
|
|
2.70 |
0.00 |
(2.70) |
|
|
|
|
|
|
|
|
|
|
| 58 |
Emcure Pharmaceuticals Limited |
|
Avet Lifesciences Private Limited |
|
Enterprise over which Key Management Personnel have control |
Any other transaction |
Reimbursement of expenses made |
0.00 |
Not applicable |
|
|
219.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 59 |
Emcure Pharmaceuticals Limited |
|
H.M. Sales Corporation |
|
Subsidiaries |
Any other transaction |
Reimbursement of expenses made |
0.00 |
Not applicable |
|
|
0.30 |
(0.30) |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 60 |
Emcure Pharmaceuticals Limited |
|
Uth Beverages Factory Pvt. Ltd. |
|
Enterprise over which Key Management Personnel have control |
Any other transaction |
Reimbursement of expenses made |
0.00 |
Not applicable |
|
|
6.20 |
(0.80) |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 61 |
Emcure Pharmaceuticals Limited |
|
Tillomed Italia S.R.L, Italy |
|
Subsidiaries |
Any other transaction |
Reimbursement of expenses made |
0.00 |
Not applicable |
|
|
4.40 |
0.00 |
(4.40) |
|
|
|
|
|
|
|
|
|
|
| 62 |
Emcure Pharmaceuticals Limited |
|
Tillomed Malta Limited |
|
Subsidiaries |
Any other transaction |
Reimbursement of expenses made |
0.00 |
Not applicable |
|
|
20.30 |
(17.80) |
(38.30) |
|
|
|
|
|
|
|
|
|
|
| 63 |
Emcure Pharmaceuticals Limited |
|
Gennova Biopharmaceuticals Limited |
|
Subsidiaries |
Any other transaction |
Reimbursement of expenses received |
0.00 |
Not applicable |
|
|
111.90 |
282.60 |
73.10 |
|
|
|
|
|
|
|
|
|
|
| 64 |
Emcure Pharmaceuticals Limited |
|
Zuventus Healthcare Limited |
|
Subsidiaries |
Any other transaction |
Reimbursement of expenses received |
0.00 |
Not applicable |
|
|
90.00 |
87.00 |
32.40 |
|
|
|
|
|
|
|
|
|
|
| 65 |
Emcure Pharmaceuticals Limited |
|
Emcutix Biopharmaceuticals Limited |
|
Subsidiaries |
Any other transaction |
Reimbursement of expenses received |
0.00 |
Not applicable |
|
|
1.80 |
6.20 |
8.30 |
|
|
|
|
|
|
|
|
|
|
| 66 |
Emcure Pharmaceuticals Limited |
|
Emcure Wellness Private Limited |
|
Subsidiaries |
Any other transaction |
Reimbursement of expenses received |
0.00 |
Not applicable |
|
|
0.90 |
1.30 |
2.30 |
|
|
|
|
|
|
|
|
|
|
| 67 |
Emcure Pharmaceuticals Limited |
|
Tillomed Laboratories Limited |
|
Subsidiaries |
Any other transaction |
Reimbursement of expenses received |
0.00 |
Not applicable |
|
|
247.10 |
1,120.90 |
1,393.20 |
|
|
|
|
|
|
|
|
|
|
| 68 |
Emcure Pharmaceuticals Limited |
|
Tillomed Malta Limited |
|
Subsidiaries |
Any other transaction |
Reimbursement of expenses received |
0.00 |
Not applicable |
|
|
8.80 |
20.40 |
4.20 |
|
|
|
|
|
|
|
|
|
|
| 69 |
Emcure Pharmaceuticals Limited |
|
Marcan Pharmaceuticals Inc. |
|
Subsidiaries |
Any other transaction |
Reimbursement of expenses received |
0.00 |
Not applicable |
|
|
42.90 |
61.30 |
104.30 |
|
|
|
|
|
|
|
|
|
|
| 70 |
Emcure Pharmaceuticals Limited |
|
Mantra Pharma Inc |
|
Holding-Subsidiary |
Any other transaction |
Reimbursement of expenses received |
0.00 |
Not applicable |
|
|
5.30 |
78.40 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 71 |
Emcure Pharmaceuticals Limited |
|
Heritage Pharmaceuticals Inc. |
|
Enterprise over which Key Management Personnel have control |
Any other transaction |
Reimbursement of expenses received |
0.00 |
Not applicable |
|
|
16.60 |
52.10 |
16.70 |
|
|
|
|
|
|
|
|
|
|
| 72 |
Emcure Pharmaceuticals Limited |
|
Gennova Biopharmaceuticals Limited |
|
Subsidiaries |
Any other transaction |
Rent income |
3,000.00 |
Approved |
|
|
882.60 |
892.20 |
479.20 |
|
|
|
|
|
|
|
|
|
|
| 73 |
Emcure Pharmaceuticals Limited |
|
Zuventus Healthcare Limited |
|
Subsidiaries |
Any other transaction |
Rent income |
300.00 |
Approved |
|
|
30.00 |
0.00 |
5.80 |
|
|
|
|
|
|
|
|
|
|
| 74 |
Emcure Pharmaceuticals Limited |
|
Emcutix Biopharmaceuticals Limited |
|
Subsidiaries |
Any other transaction |
Rent income |
100.00 |
Approved |
|
|
5.90 |
2.20 |
8.60 |
|
|
|
|
|
|
|
|
|
|
| 75 |
Emcure Pharmaceuticals Limited |
|
Emcure Wellness Private Limited |
|
Subsidiaries |
Any other transaction |
Rent income |
600.00 |
Approved |
|
|
4.10 |
1.50 |
5.90 |
|
|
|
|
|
|
|
|
|
|
| 76 |
Emcure Pharmaceuticals Limited |
|
Emcure Lifesciences Private Limited |
|
Subsidiaries |
Any other transaction |
Rent income |
600.00 |
Approved |
|
|
0.20 |
0.10 |
0.30 |
|
|
|
|
|
|
|
|
|
|
| 77 |
Emcure Pharmaceuticals Limited |
|
Incredible Ventures Private Limited |
|
Subsidiaries |
Any other transaction |
Rent income |
50.00 |
Approved |
|
|
0.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 78 |
Emcure Pharmaceuticals Limited |
|
Gennova Biopharmaceuticals Limited |
|
Subsidiaries |
Any other transaction |
Financial guarantee fees charged |
300.00 |
Approved |
|
|
90.50 |
90.30 |
106.80 |
|
|
|
|
|
|
|
|
|
|
| 79 |
Emcure Pharmaceuticals Limited |
|
Tillomed Laboratories Limited |
|
Holding-Subsidiary |
Any other transaction |
Financial guarantee fees charged |
500.00 |
Approved |
|
|
104.70 |
124.40 |
230.40 |
|
|
|
|
|
|
|
|
|
|
| 80 |
Emcure Pharmaceuticals Limited |
|
Mantra Pharma Inc |
|
Holding-Subsidiary |
Any other transaction |
Financial guarantee fees charged |
1,200.00 |
Approved |
|
|
84.80 |
80.50 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 81 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharmaceuticals Mena FZ-LLC. |
|
Subsidiaries |
Any other transaction |
Financial guarantee fees charged |
240.00 |
Approved |
|
|
15.60 |
14.20 |
25.00 |
|
|
|
|
|
|
|
|
|
|
| 82 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharma Philippines Inc |
|
Subsidiaries |
Any other transaction |
Financial guarantee fees charged |
240.00 |
Approved |
|
|
8.00 |
12.20 |
20.60 |
|
|
|
|
|
|
|
|
|
|
| 83 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharma Chile SpA |
|
Subsidiaries |
Any other transaction |
Financial guarantee fees charged |
240.00 |
Approved |
|
|
15.60 |
47.20 |
64.70 |
|
|
|
|
|
|
|
|
|
|
| 84 |
Emcure Pharmaceuticals Limited |
|
Tillomed Italia S.R.L, Italy |
|
Subsidiaries |
Any other transaction |
Financial guarantee fees charged |
200.00 |
Approved |
|
|
48.30 |
27.60 |
75.70 |
|
|
|
|
|
|
|
|
|
|
| 85 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharmaceuticals Mena FZ-LLC. |
|
Subsidiaries |
Any other transaction |
Marketing Support Fees (classified under Advertisement & Promotional Material) |
6,000.00 |
Approved |
|
|
108.50 |
(1,404.90) |
(1,562.80) |
|
|
|
|
|
|
|
|
|
|
| 86 |
Emcure Pharmaceuticals Limited |
|
Emcure Nigeria Limited |
|
Subsidiaries |
Any other transaction |
Marketing Support Fees (classified under Advertisement & Promotional Material) |
600.00 |
Approved |
|
|
20.60 |
(143.40) |
(130.80) |
|
|
|
|
|
|
|
|
|
|
| 87 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharma Mexico S.A. DE C.V. |
|
Subsidiaries |
Any other transaction |
Marketing Support Fees (classified under Advertisement & Promotional Material) |
2,400.00 |
Approved |
|
|
393.40 |
(292.60) |
(317.90) |
|
|
|
|
|
|
|
|
|
|
| 88 |
Emcure Pharmaceuticals Limited |
|
Emcure Brasil Farmaceutica Ltda. |
|
Subsidiaries |
Any other transaction |
Marketing Support Fees (classified under Advertisement & Promotional Material) |
1,200.00 |
Approved |
|
|
15.30 |
(163.70) |
(158.90) |
|
|
|
|
|
|
|
|
|
|
| 89 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharmaceuticals Pty Ltd. |
|
Subsidiaries |
Any other transaction |
Marketing Support Fees (classified under Advertisement & Promotional Material) |
1,200.00 |
Approved |
|
|
129.20 |
(268.20) |
(265.90) |
|
|
|
|
|
|
|
|
|
|
| 90 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharma Philippines Inc |
|
Subsidiaries |
Any other transaction |
Marketing Support Fees (classified under Advertisement & Promotional Material) |
1,000.00 |
Approved |
|
|
114.20 |
(109.40) |
(114.20) |
|
|
|
|
|
|
|
|
|
|
| 91 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharmaceuticals South Africa (Pty) Ltd |
|
Subsidiaries |
Any other transaction |
Marketing Support Fees (classified under Advertisement & Promotional Material) |
5,000.00 |
Approved |
|
|
1,683.80 |
0.00 |
(1,684.30) |
|
|
|
|
|
|
|
|
|
|
| 92 |
Emcure Pharmaceuticals Limited |
|
Emcure Pharmaceuticals Dominicana, S.A.S |
|
Subsidiaries |
Any other transaction |
Marketing Support Fees (classified under Advertisement & Promotional Material) |
900.00 |
Approved |
|
|
66.40 |
0.00 |
(66.40) |
|
|
|
|
|
|
|
|
|
|
| 93 |
Emcure Pharmaceuticals Limited |
|
Marcan Pharmaceuticals Inc. |
|
Subsidiaries |
Any other transaction |
Corporate Overhead Cross Charge (Income) (classified under other income) |
1,500.00 |
Approved |
|
|
527.70 |
161.40 |
693.60 |
|
|
|
|
|
|
|
|
|
|
| 94 |
Emcure Pharmaceuticals Limited |
|
Tillomed Laboratories Limited |
|
Subsidiaries |
Any other transaction |
Corporate Overhead Cross Charge (Income) (classified under other income) |
3,000.00 |
Approved |
|
|
1,099.10 |
1,791.40 |
2,945.20 |
|
|
|
|
|
|
|
|
|
|
| 95 |
Emcure Pharmaceuticals Limited |
|
Gennova Biopharmaceuticals Limited |
|
Subsidiaries |
Any other transaction |
Corporate Overhead Cross Charge (Income) (classified under other income) |
1,200.00 |
Approved |
|
|
10.70 |
13.40 |
12.50 |
|
|
|
|
|
|
|
|
|
|
| 96 |
Emcure Pharmaceuticals Limited |
|
Emcutix Biopharmaceuticals Limited |
|
Subsidiaries |
Any other transaction |
Corporate Overhead Cross Charge (Income) (classified under other income) |
600.00 |
Approved |
|
|
4.00 |
4.50 |
9.10 |
|
|
|
|
|
|
|
|
|
|
| 97 |
Emcure Pharmaceuticals Limited |
|
Zuventus Healthcare Limited |
|
Subsidiaries |
Any other transaction |
Corporate Overhead Cross Charge (Income) (classified under other income) |
1,000.00 |
Approved |
|
|
25.20 |
0.00 |
29.30 |
|
|
|
|
|
|
|
|
|
|
| 98 |
Emcure Pharmaceuticals Limited |
|
Emcure Lifesciences Private Limited |
|
Subsidiaries |
Any other transaction |
Corporate Overhead Cross Charge (Income) (classified under other income) |
600.00 |
Approved |
|
|
1.40 |
0.00 |
1.60 |
|
|
|
|
|
|
|
|
|
|
| 99 |
Emcure Pharmaceuticals Limited |
|
Emcure Wellness Private Limited |
|
Subsidiaries |
Any other transaction |
Corporate Overhead Cross Charge (Income) (classified under other income) |
600.00 |
Approved |
|
|
0.80 |
0.00 |
0.90 |
|
|
|
|
|
|
|
|
|
|
| 100 |
Emcure Pharmaceuticals Limited |
|
Mantra Pharma Inc |
|
Holding-Subsidiary |
Any other transaction |
Corporate Overhead Cross Charge (Income) (classified under other income) |
1,200.00 |
Approved |
|
|
108.90 |
145.60 |
18.30 |
|
|
|
|
|
|
|
|
|
|
| 101 |
Emcure Pharmaceuticals Limited |
|
Zuventus Healthcare Limited |
|
Subsidiaries |
Any other transaction |
Rent expense |
100.00 |
Approved |
|
|
16.20 |
(5.80) |
(2.90) |
|
|
|
|
|
|
|
|
|
|
| 102 |
Emcure Pharmaceuticals Limited |
|
Mr. Sunil Mehta |
|
Promoters |
Any other transaction |
Rent expense |
50.00 |
Approved |
|
|
1.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 103 |
Emcure Pharmaceuticals Limited |
|
Mr. Sanjay Mehta |
|
Promoters Group |
Any other transaction |
Rent expense |
50.00 |
Approved |
|
|
1.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 104 |
Emcure Pharmaceuticals Limited |
|
Mrs. Bhavana Mehta |
|
Promoters Group |
Any other transaction |
Rent expense |
50.00 |
Approved |
|
|
0.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 105 |
Gennova Biopharmaceuticals Limited |
|
H.M. Sales Corporation |
|
Director and relative of Director are partner |
Sale of goods or services |
|
1,050.00 |
Approved |
|
|
32.00 |
0.40 |
30.60 |
|
|
|
|
|
|
|
|
|
|
| 106 |
Gennova Biopharmaceuticals Limited |
|
H.M. Sales Corporation |
|
Director and relative of Director are partner |
Any other transaction |
Commission expenses |
1,250.00 |
Approved |
|
|
17.00 |
5.50 |
8.10 |
|
|
|
|
|
|
|
|
|
|
| 107 |
Gennova Biopharmaceuticals Limited |
|
Mr. Samit Mehta |
|
Promoters |
Remuneration |
|
87.50 |
Approved |
|
|
87.50 |
18.60 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 108 |
Gennova Biopharmaceuticals Limited |
|
Dr. Rohan Gurjar |
|
Relative of Director |
Remuneration |
|
19.70 |
Approved |
|
|
19.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 109 |
Zuventus Healthcare Limited |
|
H.M. Sales Corporation |
|
Enterprise over which Key Management Personnel have significant influence |
Sale of goods or services |
|
300.00 |
Approved |
|
|
(162.00) |
487.60 |
317.30 |
|
|
|
|
|
|
|
|
|
|
| 110 |
Zuventus Healthcare Limited |
|
H.M. Sales Corporation |
|
Enterprise over which Key Management Personnel have significant influence |
Any other transaction |
Commission expenses |
300.00 |
Approved |
|
|
52.90 |
21.20 |
27.10 |
|
|
|
|
|
|
|
|
|
|
| 111 |
Zuventus Healthcare Limited |
|
H.M. Sales Corporation |
|
Enterprise over which Key Management Personnel have significant influence |
Any other transaction |
Reimbursement of expenses made |
0.00 |
Not applicable |
|
|
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 112 |
Emcutix Biopharmaceuticals Limited |
|
H.M. Sales Corporation |
|
Enterprise over which Key Management Personnel have significant influence |
Sale of goods or services |
|
2,200.00 |
Approved |
|
|
288.00 |
44.80 |
356.40 |
|
|
|
|
|
|
|
|
|
|
| 113 |
Emcutix Biopharmaceuticals Limited |
|
H.M. Sales Corporation |
|
Enterprise over which Key Management Personnel have significant influence |
Interest paid |
|
0.00 |
Not applicable |
|
|
1.30 |
0.60 |
0.60 |
|
|
|
|
|
|
|
|
|
|
| 114 |
Emcutix Biopharmaceuticals Limited |
|
H.M. Sales Corporation |
|
Enterprise over which Key Management Personnel have significant influence |
Any other transaction |
Trade/Security deposit accepted |
0.00 |
Not applicable |
|
|
0.00 |
35.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 115 |
Emcutix Biopharmaceuticals Limited |
|
H.M. Sales Corporation |
|
Enterprise over which Key Management Personnel have significant influence |
Any other transaction |
Commission expenses |
1,320.00 |
Approved |
|
|
2.80 |
0.00 |
1.20 |
|
|
|
|
|
|
|
|
|
|
| 116 |
Gennova Biopharmaceuticals Limited |
|
Rutav Mehta |
|
Promoter Group |
Remuneration |
Acquisition of shares |
9.60 |
Approved |
|
|
9.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 117 |
Emcure Pharmaceuticals Limited |
|
Mr. Satish Mehta |
|
Promoters |
Any other transaction |
Acquisition of shares |
0.00 |
Not applicable |
|
|
23.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 118 |
Emcure Pharmaceuticals Limited |
|
Mr. Sunil Mehta |
|
Promoters |
Any other transaction |
Acquisition of shares |
0.00 |
Not applicable |
|
|
24.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 119 |
Emcure Pharmaceuticals Limited |
|
Mr. Samit Mehta |
|
Promoters |
Any other transaction |
Acquisition of shares |
0.00 |
Not applicable |
|
|
8.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 120 |
Emcure Pharmaceuticals Limited |
|
Mrs. Bhavana Mehta |
|
Promoter Group |
Any other transaction |
Acquisition of shares |
0.00 |
Not applicable |
|
|
8.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 121 |
Emcure Pharmaceuticals Limited |
|
Mr. Sanjay Mehta |
|
Promoter Group |
Any other transaction |
Acquisition of shares |
0.00 |
Not applicable |
|
|
24.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 122 |
Emcure Pharmaceuticals Limited |
|
Torrent Urja 37 Private limited |
|
Associate company |
Investment |
|
0.00 |
Not applicable |
|
|
111.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 123 |
Emcure Pharmaceuticals Limited |
|
Torrent Urja 37 Private limited |
|
Associate company |
Purchase of goods or services |
|
1,000.00 |
Not applicable |
|
|
117.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 124 |
Emcure Pharmaceuticals Limited |
|
Sunsure Solarpark Twelve Private Lim |
|
Associate company |
Purchase of goods or services |
|
1,500.00 |
Not applicable |
|
|
445.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
|
Total value of transaction during the reporting period |
2,07,339.30 |
|
|